A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Public ClinicalTrials.gov record NCT07155668. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-label Study Evaluating the Safety, Tolerability and Pharmacokinetics of VRDN-003 Administered Subcutaneously in Participants With Thyroid Eye Disease (TED)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a clinical trial assessing the safety, tolerability and pharmacokinetics (PK) of an investigational drug, VRDN-003, in participants with TED (Thyroid Eye Disease)
Study identification
- NCT ID
- NCT07155668
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2025 (Actual)
- Primary completion
- May 28, 2026 (Actual)
- Completion
- May 28, 2026 (Actual)
- Last update posted
- Jun 25, 2026
2025 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| United Medical Research Institute | Inglewood | California | 90301 | — |
| C&A Clinical Trials Corp | Cape Coral | Florida | 33990 | — |
| Ilumina Medical Research | Kissimmee | Florida | 34744 | — |
| Med-Care Research | Miami | Florida | 33125 | — |
| Continental Clinical Research, llc | Miami | Florida | 33144 | — |
| Hype Clinical Research, LLC | Miami | Florida | 33145 | — |
| Advanced Quality Medical Research, LLC | Orland Park | Illinois | 60462 | — |
| Ophthalmic Consultants of Boston | East Weymouth | Massachusetts | 02189 | — |
| Fraser Eye Center | Fraser | Michigan | 48026 | — |
| Kahana Oculoplastic and Orbital Surgery | Livonia | Michigan | 48152 | — |
| Vector Clinical Trials | Sparks | Nevada | 89128 | — |
| Baylor College of Medicine, Alkek Eye Center | Houston | Texas | 77030 | — |
| Neuro Eye Clinical Trials INC | Houston | Texas | 77074 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07155668, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 25, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07155668 live on ClinicalTrials.gov.